Personalis

Personalis is partnering with pharmaceutical companies to advance the development of more effective cancer immunotherapies by providing highly accurate and comprehensive tumor immunogenomics. Our ACE ImmunoID Platform combines our augmented exome and transcriptome assays with advanced analytics to support our pharmaceutical partners at all stages of the drug development process; from discovery and translational research studies and clinical trials, to post-approval and commercialization. Mission: Our mission is to help cancer patients by enabling the next generation of personalized immuno-oncology therapeutics and diagnostics through rigorous innovation.